Tech Center 1600 • Art Units: 1600 1633 1634 1641 1674 1677
This examiner grants 0% of resolved cases
Juliana Irene Candelaria is an examiner in Tech Center 1600 and Art Unit 1600. She has 3 resolved cases on record. Her allowance rate is 0.0 percent, meaning that none of her resolved cases resulted in an allowance. The median days to allowance for her cases is 1122, which is the time recorded for these resolutions. Her interview lift is 0.0 percent, indicating no change in outcome from interviews in these instances.
The 3 resolved cases are the basis for the 0.0 percent allowance rate and 0.0 percent interview lift. This very limited data set makes it difficult to establish a clear pattern for her examination style. Practitioners should note the 1600 tech center and 1600 art unit when approaching her cases. The 1122 days to allowance is the only available timeline metric. More cases are needed to establish a pattern beyond these 3 resolved cases. The 0.0 percent allowance rate reflects the current data available for her profile.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18344973 | MATERIALS AND METHODS FOR BIOENGINEERED IPSC POPULATIONS | Final Rejection | JANSSEN BIOTECH, INC. |
| 18733979 | HYDROGEL, INKJET INK, METHOD FOR PRODUCING CELL CULTURE BODY, AND CELL-CONTAINING GEL PARTICLES AND METHOD FOR PRODUCING SAME | Non-Final OA | RICOH COMPANY, LTD. |
| 18340917 | NON-HUMAN ANIMALS HAVING A HUMANIZED CLEC9A GENE | Final Rejection | Regeneron Pharmaceuticals, Inc. |
| 18115285 | BIOREACTOR FOR ANTIBODY PRODUCTION | Final Rejection | Regeneron Pharmaceuticals, Inc. |
| 18905388 | METHODS AND MATERIALS FOR GALGT2 GENE THERAPY | Non-Final OA | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL |
| 18854168 | METHODS AND MATERIALS FOR TREATING SYNGAP1-ASSOCIATED NEURODEVELOPMENTAL DISORDERS | Non-Final OA | The Johns Hopkins University |
| 15550951 | MATERIALS AND METHODS FOR TREATMENT OF HEMOGLOBINOPATHIES | Final Rejection | William Marsh Rice University |
| 18717851 | Method of Production of Organoids and Uses Thereof | Non-Final OA | Centre National de la Recherche Scientifique |
| 18342930 | LUNG CANCER MODELING USING NORMAL LUNG ORGANOID WITH LUNG CANCER CELLS | Final Rejection | THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION |
| 18425313 | EXOSOME, PREPARATION METHOD THEREOF, USE THEREOF AND PHARMACEUTICAL COMPOSITION | Non-Final OA | China Medical University |
| 17815469 | EXOSOME ENRICHMENT BY ULTRAFILTRATION | Non-Final OA | NATIONAL YANG MING CHIAO TUNG UNIVERSITY |
| 18352730 | COMPOSITIONS AND METHODS FOR NEUROPROTECTION AND/OR NEUROREGENERATION | Non-Final OA | The Children's Medical Center Corporation |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy